common image
prescriptionPrescription Required

Abstet 250 mg Tablet

120 Tablets in 1 Bottle

43% OFF
You save ₹ 18960.00

(Inclusive of all taxes)

Biocon Biologics India Ltd
Abiraterone Acetate 250 mg

Introduction of Abstet Tablet

Abstet 250 mg Tablet is a medication used to treat prostate cancer . Abstet 250 mg Tablet is helpful in the prevention of the testosterone flare at the initiation of GnRH agonist therapy in men with prostate cancer who have already received chemotherapy treatment. Abstet 250 mg Tablet prevents the spread of prostate cancer to other body parts. Abstet 250 mg Tablet is also known as second-line therapy as it is given to those who have stopped responding to hormone therapy.Abstet 250 mg Tablet decreases the hormone production in the male body such as testosterone/androgens. Abstet 250 mg Tablet blocks its production in three body parts-, adrenal glands, testes, and the tumour. However, Abstet 250 mg Tablet doesn’t cure prostate cancer, but it helps to control the disease.

Uses of Abstet Tablet

  • Prostate cancer

Benefits of Abstet Tablet

Abstet 250 mg Tablet decreases the production of testosterone in male. In this way, the cancer cells decreases or stop growing due to low testosterone level in body.

Side Effects of Abstet Tablet

Below are possible adverse effects of Abstet 250 mg Tablet.

Most Common Side Effects of Abstet Tablet

  • Urinary tract infection
  • Hypokalemia
  • Hypertension
  • Diarrhea
  • Peripheral edema

Common Side Effects of Abstet Tablet

  • Hypertriglyceridaemia
  • Sepsis
  • Cardiac failure
  • Angina pectoris
  • Arrhythmia
  • Atrial fibrillation
  • Tachycardia
  • Dyspepsia (indigestion)
  • Rash
  • Alanine aminotransferase increased

How to Use Abstet Tablet?

Take Abstet 250 mg Tablet in the dose and duration as advised by your doctor. It is a pill and you can consume it by mouth. Abstet 250 mg Tablet should be consumed on an empty stomach Swallow it whole,do not chew, crush or break it.

How Abstet Tablet Works?

Abstet 250 mg Tablet inhibits CYP17A1, which manifests as two enzymes, 17α-hydroxylase and 17,20-lyase that are expressed in testicular, adrenal, and prostatic cancer tissues. It stops the body from producing the testosterones. It interrupts the enzymes in the prostatic tumour, adrenal and testiocular tissues and lessens the androgen amount in the body. It blocks the production of androgen in the tumor, adrenal glands and the testes as well.

Similar Medicines